Early research (Phase 1)Ended earlyNCT01906307What this trial is testingLJPC-501 in Patients With Hepatorenal SyndromeWho this might be right forHepatorenal Syndrome Type I and Type II La Jolla Pharmaceutical Company 6
Large-scale testing (Phase 3)Ended earlyNCT00742339What this trial is testingTerlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal SyndromeWho this might be right forCirrhosisHepatorenal Syndrome University of Padova 49